EP3404023 - BIHETEROCYCLIC COMPOUND [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 10.06.2021 Database last updated on 05.07.2024 | |
Former | Request for examination was made Status updated on 19.10.2018 | ||
Former | The international publication has been made Status updated on 21.07.2017 | Most recent event Tooltip | 26.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Sumitomo Pharma Co., Ltd. 6-8, Doshomachi 2-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | [2022/25] |
Former [2018/47] | For all designated states Sumitomo Dainippon Pharma Co., Ltd. 6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi Osaka 541-8524 / JP | Inventor(s) | 01 /
WATANABE, Hitoshi c/o Sumitomo Dainippon Pharma Co. Ltd. 1-98 Kasugadenaka 3-chome Konohana-ku Osaka-shi Osaka 554-0022 / JP | 02 /
ISOBE, Yoshiaki c/o Sumitomo Dainippon Pharma Co. Ltd. 1-98 Kasugadenaka 3-chome Konohana-ku Osaka-shi Osaka 554-0022 / JP | 03 /
KIMURA, Hidenori c/o Sumitomo Dainippon Pharma Co., Ltd. 13-1 Kyobashi 1-chome Chuo-ku Tokyo 1048356 / JP | 04 /
FUJIWARA, Yuji c/o Sumitomo Dainippon Pharma Co. Ltd. 3-45 Kurakakiuchi 1-chome Ibaraki-shi Osaka 567-0878 / JP | [2018/47] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2018/47] | Application number, filing date | 17738476.5 | 12.01.2017 | [2018/47] | WO2017JP00819 | Priority number, date | JP20160006205 | 15.01.2016 Original published format: JP 2016006205 | JP20160173510 | 06.09.2016 Original published format: JP 2016173510 | [2018/47] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017122722 | Date: | 20.07.2017 | Language: | JA | [2017/29] | Type: | A1 Application with search report | No.: | EP3404023 | Date: | 21.11.2018 | Language: | EN | [2018/47] | Search report(s) | International search report - published on: | JP | 20.07.2017 | (Supplementary) European search report - dispatched on: | EP | 15.10.2019 | Classification | IPC: | C07D311/22, A61K31/352, A61K31/4192, A61K31/4709, A61K31/519, A61P9/10, A61P25/00, A61P25/02, A61P25/28, A61P27/02, A61P43/00, C07D405/04, C07D405/14, C07D471/04, C07D405/12 | [2019/46] | CPC: |
C07D405/14 (EP,US);
A61K31/352 (EP,US);
A61K31/4192 (EP,US);
A61K31/4709 (EP,US);
A61K31/519 (EP,US);
A61P25/28 (EP,US);
A61P27/04 (EP,US);
C07D311/22 (EP,US);
C07D405/04 (EP,US);
C07D471/04 (EP,US)
(-)
|
Former IPC [2018/47] | C07D311/22, A61K31/352, A61K31/4192, A61K31/4709, A61K31/519, A61P9/10, A61P25/00, A61P25/02, A61P25/28, A61P27/02, A61P43/00, C07D405/04, C07D405/14, C07D471/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/47] | Title | German: | BIHETEROCYCLISCHE VERBINDUNG | [2018/47] | English: | BIHETEROCYCLIC COMPOUND | [2018/47] | French: | COMPOSÉ BIHÉTÉROCYCLIQUE | [2018/47] | Entry into regional phase | 13.08.2018 | Translation filed | 13.08.2018 | National basic fee paid | 13.08.2018 | Search fee paid | 13.08.2018 | Designation fee(s) paid | 13.08.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 13.08.2018 | Examination requested [2018/47] | 14.05.2020 | Amendment by applicant (claims and/or description) | 09.06.2021 | Despatch of a communication from the examining division (Time limit: M04) | 18.10.2021 | Reply to a communication from the examining division | 10.10.2022 | Despatch of a communication from the examining division (Time limit: M04) | 04.11.2022 | Reply to a communication from the examining division | Fees paid | Renewal fee | 24.01.2019 | Renewal fee patent year 03 | 22.01.2020 | Renewal fee patent year 04 | 25.01.2021 | Renewal fee patent year 05 | 24.01.2022 | Renewal fee patent year 06 | 24.01.2023 | Renewal fee patent year 07 | 25.01.2024 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [A]WO0209756 (SUMITOMO PHARMA [JP], et al) [A] 1-28 * , claims; examples & US 2003/0166711 A1 claims; examples & EP 1306093 A1 & DE 60130769 D & AU 7669401 A *; | [A]JP2006335683 (DAINIPPON SUMITOMO PHARMA CO) [A] 1-28 * , claims; examples (Family: none) *; | [A]JP2011046734 (DAINIPPON SUMITOMO PHARMA CO) [A] 1-28 * , claims; examples & US 2005/0119334 A1 claims; examples & WO 2003/062243 A1 & EP 1475382 A1 *; | [A]WO2012115182 (UNIV KEIO [JP], et al) [A] 1-28 * , claims; examples & US 2014/0018416 A1 claims; examples & EP 2679226 A1 & AU 2012221110 A & CA 2827869 A & CN 103379906 A & KR 10-2014-0026368 A *; | [PA]JP2016037472 (DAINIPPON SUMITOMO PHARMA CO) [PA] 1-28* , claims; examples (Family: none) * | by applicant | WO0209756 | WO03062243 | WO03062440 | WO03099762 | WO2005000838 | WO2012018069 | WO2012115182 | - Cell, (19930000), vol. 75, page 217 | - Cell, (19930000), vol. 75, page 1389 | - Nature Medicine, (20060000), vol. 3, no. 12, page 1398 | - PLOS ONE, (20120000), vol. 7, no. 11, page e47716 | - "4th Series of Experimental Chemistry", Jikken Kagaku Kouza, MARUZEN, vol. 22 | - Angew. Chem. Int. Ed.,, (20130000), vol. 52, pages 3421 - 3424 | - Chem Lett., (20070000), vol. 36, page 1382 | - J. Med. Chem., (20150000), vol. 58, no. 5, pages 2195 - 2205 | - Tetrahedron, (20070000), vol. 63, no. 2, pages 474 - 491 | - Bioorg. Med. Chem., (20050000), vol. 13, pages 1661 - 1671 | - Tetrahedron Lett., (20090000), vol. 50, pages 6494 - 6497 | - Heterocycles, (20050000), vol. 65, pages 2095 - 2105 | - Org. Lett., (20140000), vol. 16, pages 3568 - 3571 | - "4th Series of Experimental Chemistry", Jikken . Kagaku Kouza, MARUZEN, vol. 22 | - Angew. Chem. Int. Ed., (20130000), vol. 52, pages 3421 - 3424 |